- Home
- LNTH vs MASI Comparison
LNTH vs MASI Comparison
Compare LNTH & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- MASI
- Stock Information
- Founded
- LNTH 1956
- MASI 1989
- Country
- LNTH United States
- MASI United States
- Employees
- LNTH N/A
- MASI N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MASI Medical/Dental Instruments
- Sector
- LNTH Health Care
- MASI Health Care
- Exchange
- LNTH Nasdaq
- MASI Nasdaq
- Market Cap
- LNTH 7.5B
- MASI 8.2B
- IPO Year
- LNTH 2015
- MASI 2007
- Fundamental
- Price
- LNTH $80.28
- MASI $163.80
- Analyst Decision
- LNTH Strong Buy
- MASI Buy
- Analyst Count
- LNTH 5
- MASI 6
- Target Price
- LNTH $133.80
- MASI $187.00
- AVG Volume (30 Days)
- LNTH 1.2M
- MASI 607.7K
- Earning Date
- LNTH 05-07-2025
- MASI 05-06-2025
- Dividend Yield
- LNTH N/A
- MASI N/A
- EPS Growth
- LNTH N/A
- MASI N/A
- EPS
- LNTH 3.53
- MASI N/A
- Revenue
- LNTH $1,536,699,000.00
- MASI $2,126,800,000.00
- Revenue This Year
- LNTH $5.81
- MASI N/A
- Revenue Next Year
- LNTH $12.26
- MASI $7.82
- P/E Ratio
- LNTH $22.52
- MASI N/A
- Revenue Growth
- LNTH 12.53
- MASI 16.68
- 52 Week Low
- LNTH $74.34
- MASI $101.61
- 52 Week High
- LNTH $126.89
- MASI $194.88
- Technical
- Relative Strength Index (RSI)
- LNTH 29.71
- MASI 53.69
- Support Level
- LNTH $78.61
- MASI $142.80
- Resistance Level
- LNTH $83.60
- MASI $165.28
- Average True Range (ATR)
- LNTH 3.81
- MASI 4.67
- MACD
- LNTH -3.05
- MASI 0.58
- Stochastic Oscillator
- LNTH 5.51
- MASI 81.33
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About MASI Masimo Corporation
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.